News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
855,696 Results
Type
Article (87071)
Company Profile (704)
Press Release (767906)
Multimedia
Podcasts (156)
Webinars (21)
Section
Business (232913)
Career Advice (4135)
Deals (39772)
Drug Delivery (131)
Drug Development (91152)
Employer Resources (200)
FDA (18218)
Job Trends (17377)
News (397039)
Policy (39861)
Tag
Academia (3002)
Academic (2)
Accelerated approval (15)
Adcomms (33)
Allergies (111)
Alliances (56978)
ALS (125)
Alzheimer's disease (1621)
Antibody-drug conjugate (ADC) (195)
Approvals (18194)
Artificial intelligence (421)
Autoimmune disease (39)
Automation (22)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (139)
Biotechnology (482)
Bladder cancer (110)
Brain cancer (44)
Breast cancer (416)
Cancer (3303)
Cardiovascular disease (264)
Career advice (3544)
Career pathing (34)
CAR-T (218)
CDC (43)
Cell therapy (604)
Cervical cancer (26)
Clinical research (74616)
Collaboration (1187)
Company closure (4)
Compensation (798)
Complete response letters (42)
COVID-19 (2921)
CRISPR (71)
C-suite (419)
Cystic fibrosis (126)
Data (3377)
Decentralized trials (2)
Denatured (56)
Depression (85)
Diabetes (391)
Diagnostics (7015)
Digital health (26)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (196)
Drug pricing (163)
Drug shortages (36)
Duchenne muscular dystrophy (171)
Earnings (98523)
Editorial (51)
Employer branding (25)
Employer resources (169)
Events (131759)
Executive appointments (933)
FDA (20286)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (1063)
Gene editing (154)
Generative AI (42)
Gene therapy (477)
GLP-1 (969)
Government (5310)
Grass and pollen (7)
Guidances (323)
Healthcare (20921)
HIV (47)
Huntington's disease (32)
IgA nephropathy (48)
Immunology and inflammation (198)
Immuno-oncology (16)
Indications (43)
Infectious disease (3129)
Inflammatory bowel disease (171)
Inflation Reduction Act (13)
Influenza (81)
Intellectual property (142)
Interviews (813)
IPO (17911)
IRA (58)
Job creations (5194)
Job search strategy (2863)
Kidney cancer (15)
Labor market (64)
Layoffs (612)
Leadership (27)
Legal (10141)
Liver cancer (87)
Longevity (12)
Lung cancer (460)
Lymphoma (234)
Machine learning (16)
Management (65)
Manufacturing (502)
MASH (111)
Medical device (14780)
Medtech (14792)
Mergers & acquisitions (22638)
Metabolic disorders (1009)
Multiple sclerosis (107)
NASH (23)
Neurodegenerative disease (166)
Neuropsychiatric disorders (48)
Neuroscience (2443)
NextGen: Class of 2025 (7687)
Non-profit (5092)
Now hiring (52)
Obesity (508)
Opinion (298)
Ovarian cancer (108)
Pain (137)
Pancreatic cancer (137)
Parkinson's disease (209)
Partnered (26)
Patents (354)
Patient recruitment (210)
Peanut (55)
People (65872)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (23012)
Phase II (32389)
Phase III (24402)
Pipeline (2253)
Policy (264)
Postmarket research (3554)
Preclinical (10399)
Press Release (72)
Prostate cancer (161)
Psychedelics (46)
Radiopharmaceuticals (279)
Rare diseases (558)
Real estate (7404)
Recruiting (76)
Regulatory (27431)
Reports (64)
Research institute (2667)
Resumes & cover letters (650)
Rett syndrome (10)
RNA editing (13)
RSV (62)
Schizophrenia (112)
Series A (176)
Series B (128)
Service/supplier (30)
Sickle cell disease (71)
Special edition (23)
Spinal muscular atrophy (168)
Sponsored (38)
Startups (4310)
State (2)
Stomach cancer (17)
Supply chain (86)
Tariffs (77)
The Weekly (98)
Vaccines (961)
Venture capital (62)
Weight loss (349)
Women's health (53)
Worklife (20)
Date
Today (61)
Last 7 days (668)
Last 30 days (2589)
Last 365 days (33873)
2025 (21235)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1278)
Alabama (73)
Alaska (7)
Arizona (287)
Arkansas (14)
Asia (50650)
Australia (8897)
California (8390)
Canada (2560)
China (767)
Colorado (358)
Connecticut (375)
Delaware (226)
Europe (116300)
Florida (1258)
Georgia (285)
Hawaii (3)
Idaho (67)
Illinois (767)
India (36)
Indiana (408)
Iowa (19)
Japan (251)
Kansas (119)
Kentucky (34)
Louisiana (20)
Maine (75)
Maryland (1168)
Massachusetts (6378)
Michigan (286)
Minnesota (519)
Mississippi (4)
Missouri (109)
Montana (32)
Nebraska (26)
Nevada (92)
New Hampshire (75)
New Jersey (2327)
New Mexico (31)
New York (2312)
North Carolina (1300)
North Dakota (10)
Northern California (3685)
Ohio (268)
Oklahoma (17)
Oregon (48)
Pennsylvania (1789)
Puerto Rico (18)
Rhode Island (42)
South America (1654)
South Carolina (39)
South Dakota (1)
Southern California (3149)
Tennessee (136)
Texas (1305)
United States (31427)
Utah (246)
Virginia (228)
Washington D.C. (80)
Washington State (726)
West Virginia (4)
Wisconsin (89)
There are 855,696 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Neuroscience
Merck KGaA Drops up to $2B in Skyhawk Collab for RNA-Targeting Tech
Waltham, Massachusetts–based Skyhawk Therapeutics has been collecting collaborations with larger companies in spades since launching in 2018.
August 18, 2025
·
1 min read
·
Dan Samorodnitsky
GLP-1
Novo Teams Up With GoodRx for Lower-Price GLP-1s, Giving DTC Another Shot
Patients who are prescribed Wegovy or Ozempic can now use GoodRx to access the medications at just $499 a month if they skip insurance. This is not the first time Novo has partnered with a pharmacy to offer the blockbuster drugs.
August 18, 2025
·
1 min read
·
Annalee Armstrong
Sickle cell disease
Pfizer’s $5.4B GBT Bet Disappoints Again as Sickle Cell Therapy Fails in Phase III
Inclacumab, which Pfizer obtained in its 2022 acquisition of Global Blood Therapeutics, failed to significantly lower pain episodes in patients with sickle cell disease over the 48-week treatment period.
August 18, 2025
·
2 min read
·
Tristan Manalac
Funding
Gene Therapy Specialist Kriya Raises $313M
Kriya is advancing a host of gene therapies for a wide variety of chronic diseases, including geographic atrophy, trigeminal neuralgia and type 1 diabetes.
August 18, 2025
·
2 min read
·
Tristan Manalac
Pain
Tonix Wins Approval For First New Fibromyalgia Drug in Over 15 Years
In Phase III studies, Tonmya showed significantly superior analgesic effects in patients with fibromyalgia versus placebo. The sublingual pill also led to better clinical outcomes.
August 18, 2025
·
1 min read
·
Tristan Manalac
MASH
Novo Wins MASH Approval for Wegovy
The label expansion could help Novo Nordisk “help shift the momentum” for Wegovy, after a difficult start to 2025, according to analysts at BMO Capital Markets.
August 18, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Ifinatamab Deruxtecan Granted Breakthrough Therapy Designation by U.S. FDA for Patients with Pretreated Extensive-Stage Small Cell Lung Cancer
August 18, 2025
·
13 min read
Press Releases
Abcuro Appoints George Eldridge as Chief Financial Officer
August 18, 2025
·
3 min read
Press Releases
Labcorp Launches First FDA-Cleared Blood Test for Alzheimer’s Disease
August 18, 2025
·
3 min read
Press Releases
Traws Pharma Receives Approval to Proceed with Phase 2 COVID Studies with Ratutrelvir, Expects Results by Year-End 2025
August 18, 2025
·
7 min read
1 of 85,570
Next
